Exposure to low levels of hexavalent chromium: Target doses and comparative effects on two human pulmonary cell lines

Acta Biomedica de l'Ateneo Parmense

Volumn 79, Issue SUPPL. 1, 2008, Pages 104-115

  Caglieri, Andrea ^a   Goldoni, Matteo ^a   De Palma, Giuseppe ^c   Mozzoni, Paola ^a   Gemma, Simonetta ^b   Vichi, Susanna ^b   Testai, Emanuela ^b   Panico, Francesca ^d   Corradi, Massimo ^a   Tagliaferri, Sara ^a   Costa, Lucio Guido ^a  

^a UNIVERSITY OF PARMA   (Italy)

^b ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^c UNIVERSITY OF BRESCIA   (Italy)

^d UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

BEAS2B cell line; Chromium; Glutathione S transferase; Haeme oxigenase; Oxidative stress

Indexed keywords

BIOLOGICAL MARKER; CHROMIUM; GLUTATHIONE TRANSFERASE;

ARTICLE; BRONCHUS MUCOSA; CONTROLLED STUDY; CYTOTOXICITY; DNA POLYMORPHISM; HUMAN; HUMAN CELL; IN VITRO STUDY; LUNG ADENOCARCINOMA; LUNG ALVEOLUS CELL; OCCUPATIONAL EXPOSURE; OXIDATIVE STRESS;

ADENOCARCINOMA; CELL LINE; CELL LINE, TUMOR; CELL SURVIVAL; CELLS, CULTURED; CHROMIUM; HUMANS; LUNG; LUNG NEOPLASMS;

EID: 48749116084     PISSN: 03924203     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (58)

1. ATSDR (Agency for Toxic Substances and Disease Registry). Final report of toxicological profile for chromium. 2000. Atlanta.
2. De Flora S. Threshold mechanisms and site specificity in chromium(VI) carcinogenesis. Carcinogenesis 2000; 21: 533-41.
3. Gibb HJ, Lees PS, Pinsky PF, Rooney BC. Lung cancer among workers in chromium chemical production. Am J Ind Med 2000; 38: 115-26.
4. Park RM, Bena JF, Stayner LT, Smith RJ, Gibb HJ, Lees PS. Hexavalent chromium and lung cancer in the chromate industry: a quantitative risk assessment. Risk Anal 2004; 24: 1099-108.
5. IARC (International Agency for Research on Cancer). Chromium, nickel and welding. 1990. 49. Lyon. 49-255
6. Anderson RA. Nutritional role of chromium. Sci Total Environ 1981; 17: 13-29.
7. De Flora S, Bagnasco M, Serra D, Zanacchi P. Genotoxicity of chromium compounds. A review. Mutat Res 1990; 238: 99-172.
8. Alexander J, Aaseth J. Uptake of chromate in human red blood cells and isolated rat liver cells: the role of the anion carrier. Analyst 1995; 120: 931-3.
9. Sehlmeyer U, Hechtenberg S, Klyszcz H, Beyersmann D. Accumulation of chromium in Chinese hamster V79-cells and nuclei. Arch Toxicol 1990; 64: 506-8.
10. Quievryn G, Peterson E, Messer J, Zhitkovich A. Genotoxicity and mutagenicity of chromium(VI)/ascorbate-generated DNA adducts in human and bacterial cells. Biochemistry 2003; 42: 1062-70.
11. Standeven AM, Wetterhahn KE. Ascorbate is the principal reductant of chromium (VI) in rat liver and kidney ultrafiltrates. Carcinogenesis 1991; 12: 1733-7.
12. Standeven AM, Wetterhahn KE. Possible role of glutathione in chromium(VI) metabolism and toxicity in rats. Pharmacol Toxicol 1991; 68: 469-76.
13. Standeven AM, Wetterhahn KE. Ascorbate is the principal reductant of chromium(VI) in rat lung ultrafiltrates and cytosols, and mediates chromium-DNA binding in vitro. Carcinogenesis 1992; 13: 1319-24.
14. Suzuki Y. Synergism of ascorbic acid and glutathione in the reduction of hexavalent chromium in vitro. Ind Health 1990; 28: 9-19.
15. Levina A, Lay PA. Mechanistic studies of relevance to the biological activities of chromium. Coordination Chemistry Reviews 2005; 249: 281-98.
16. O'Brien TJ, Ceryak S, Patierno SR. Complexities of chromium carcinogenesis: role of cellular response, repair and recovery mechanisms. Mutat Res 2003; 533: 3-36.
17. Liu K, Husler J, Ye J, et al. On the mechanism of Cr (VI)-induced carcinogenesis: dose dependence of uptake and cellular responses. Mol Cell Biochem 2001; 222: 221-9.
18. Liu KJ, Shi X. In vivo reduction of chromium (VI) and its related free radical generation. Mol Cell Biochem 2001; 222: 41-7.
19. Ye J, Shi X. Gene expression profile in response to chromium-induced cell stress in A549 cells. Mol Cell Biochem 2001; 222: 189-97.
20. De Flora S, Wetterhahn KE. Mechanism of chromium metabolism and genotoxicity. Life Chemistry Reports 1989; 7: 169-244.
21. Zienolddiny S, Campa D, Lind H, et al. A comprehensive analysis of phase I and phase II metabolism gene polymorphisms and risk of non-small cell lung cancer in smokers. Carcinogenesis 2008.
22. Sundberg K, Johansson AS, Stenberg G, et al. Differences in the catalytic efficiencies of allelic variants of glutathione transferase P1-1 towards carcinogenic diol epoxides of polycyclic aromatic hydrocarbons. Carcinogenesis 1998; 19: 433-6.
23. Ali-Osman F, Akande O, Antoun G, Mao JX, Buolamwini J. Molecular cloning, characterization, and expression in Escherichia coli of full-length cDNAs of three human glutathione S-transferase Pi gene variants. Evidence for differential catalytic activity of the encoded proteins. J Biol Chem 1997; 272: 10004-12.
24. Kwong DMJ, Pennington DE. Stoichiometry, Kinetics, and Mechanisms of the Chromium(V1) Oxidation of L-Cysteine at Neutral pH. Inorganic Chemistry 1984; 23: 2528-32.
25. Zhitkovich A, Voitkun V, Costa M. Glutathione and free amino acids form stable complexes with DNA following exposure of intact mammalian cells to chromate. Carcinogenesis 1995; 16: 907-13.
26. Bagchi D, Stohs SJ, Downs BW, Bagchi M, Preuss HG. Cytotoxicity and oxidative mechanisms of different forms of chromium. Toxicology 2002; 180: 5-22.
27. Ding M, Shi X. Molecular mechanisms of Cr(VI)-induced carcinogenesis. Mol Cell Biochem 2002; 234-235: 293-300.
28. Lay PA, Levina A. Activation of Molecular Oxygen during the Reactions of Chromium(VI/V/IV) with Biological Reductants: Implications for Chromium-Induced Genotoxicities. J. Am. Chem. Soc. 1998; 120: 6704-14.
29. Maeng SH, Chung HW, Yu IJ, et al. Changes of 8-OH-dG levels in DNA and its base excision repair activity in rat lungs after inhalation exposure to hexavalent chromium. Mutat Res 2003; 539: 109-16.
30. Martin BD, Schoenhard JA, Hwang JM, Sugden KD. Ascorbate is a pro-oxidant in chromium-treated human lung cells. Mutat Res 2006; 610: 74-84.
31. Sugden KD, Stearns DM. The role of chromium(V) in the mechanism of chromate-induced oxidative DNA damage and cancer. J Environ Pathol Toxicol Oncol 2000; 19: 215-30.
32. Adachi S, Takemoto K, Ohshima S, Shimizu Y, Takahama M. Metal concentrations in lung tissue of subjects suffering from lung cancer. Int Arch Occup Environ Health 1991; 63: 193-7.
33. Kollmeier H, Seemann JW, Rothe G, Muller KM, Wittig P. Age, sex, and region adjusted concentrations of chromium and nickel in lung tissue. Br J Ind Med 1990; 47: 682-7.
34. Raithel HJ, Schaller KH, Kraus T, Lehnert G. Biomonitoring of nickel and chromium in human pulmonary tissue. Int Arch Occup Environ Health 1993; 65: S197-200.
35. Tsuneta Y, Ohsaki Y, Kimura K, Mikami H, Abe S, Murao M. Chromium content of lungs of chromate workers with lung cancer. Thorax 1980; 35: 294-7.
36. Vettori MV, Caglieri A, Goldoni M, et al. Analysis of oxidative stress in SK-N-MC neurons exposed to styrene-7,8-oxide. Toxicol In Vitro 2005; 19: 11-20.
37. Mossman T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assay. Journal of Imuunological Methods 1983; 65: 55-63.
38. Harries LW, Stubbins MJ, Forman D, Howard GC, Wolf CR. Identification of genetic polymorphisms at the glutathione S-transferase Pi locus and association with susceptibility to bladder, testicular and prostate cancer. Carcinogenesis 1997; 18: 641-4.
39. Ishii T, Matsuse T, Teramoto S, et al. Glutathione S-transferase P1 (GSTP1) polymorphism in patients with chronic obstructive pulmonary disease. Thorax 1999; 54: 693-6.
40. Palli D, Saieva C, Gemma S, et al. GSTT1 and GSTM1 gene polymorphisms and gastric cancer in a high-risk italian population. Int J Cancer 2005; 115: 284-9.
41. Rahman I, Li XY, Donaldson K, Harrison DJ, MacNee W. Glutathione homeostasis in alveolar epithelial cells in vitro and lung in vivo under oxidative stress. Am J Physiol 1995; 269: L285-92.
42. Tietze F. Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: applications to mammalian blood and other tissues. Anal Biochem 1969; 27: 502-22.
43. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162: 156-9.
44. Vandesompele J, De Preter K, Pattyn F, et al. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 2002; 3: RESEARCH0034.
45. Asatiani N, Sapojnikova N, Abuladze M, et al. Effects of Cr(VI) long-term and low-dose action on mammalian antioxidant enzymes (an in vitro study). J Inorg Biochem 2004; 98: 490-6.
46. Pascal LE, Tessier DM. Cytotoxicity of chromium and manganese to lung epithelial cells in vitro. Toxicol Lett 2004; 147: 143-51.
47. Dubrovskaya VA, Wetterhahn KE. Effects of Cr(VI) on the expression of the oxidative stress genes in human lung cells. Carcinogenesis 1998; 19: 1401-7.
48. He X, Lin GX, Chen MG, Zhang JX, Ma Q. Protection against chromium (VI)-induced oxidative stress and apoptosis by Nrf2. Recruiting Nrf2 into the nucleus and disrupting the nuclear Nrf2/Keap1 association. Toxicol Sci 2007; 98: 298-309.
49. Shi X, Ding M, Ye J, et al. Cr(IV) causes activation of nuclear transcription factor-kappa B, DNA strand breaks and dG hydroxylation via free radical reactions. J Inorg Biochem 1999; 75: 37-44.
50. Singh J, Carlisle DL, Pritchard DE, Patierno SR. Chromium-induced genotoxicity and apoptosis: relationship to chromium carcinogenesis (review). Oncol Rep 1998; 5: 1307-18.
51. Stohs SJ, Bagchi D. Oxidative mechanisms in the toxicity of metal ions. Free Radic Biol Med 1995; 18: 321-36.
52. Stocker R, Yamamoto Y, McDonagh AF, Glazer AN, Ames BN. Bilirubin is an antioxidant of possible physiological importance. Science 1987; 235: 1043-6.
53. Clark JE, Foresti R, Green CJ, Motterlini R. Dynamics of haem oxygenase-1 expression and bilirubin production in cellular protection against oxidative stress. Biochem J 2000; 348 Pt 3: 615-9.
54. Motterlini R, Foresti R, Intaglietta M, Winslow RM. NO-mediated activation of heme oxygenase: endogenous cytoprotection against oxidative stress to endothelium. Am J Physiol 1996; 270: H107-14.
55. Wu TW, Wu J, Li RK, Mickle D, Carey D. Albumin-bound bilirubins protect human ventricular myocytes against oxyradical damage. Biochem Cell Biol 1991; 69: 683-8.
56. Kweon MH, Adhami VM, Lee JS, Mukhtar H. Constitutive overexpression of Nrf2-dependent heme oxygenase-1 in A549 cells contributes to resistance to apoptosis induced by epigallocatechin 3-gallate. J Biol Chem 2006; 281: 33761-72.
57. Slebos DJ, Ryter SW, van der Toorn M, et al. Mitochondrial localization and function of heme oxygenase-1 in cigarette smoke-induced cell death. Am J Respir Cell Mol Biol 2007; 36: 409-17.
58. Pomeraniec Y, Grion N, Gadda L, Pannunzio V, Podesta EJ, Cymeryng CB. Adrenocorticotropin induces heme oxygenase-1 expression in adrenal cells. J Endocrinol 2004; 180: 113-24.